Multiple sclerosis and COVID-19: How could therapeutic scenarios change during the pandemic?

We read with great interest the review by Rostami Mansoor and Ghasemi-Kasman entitled "Impact of disease-modifying drugs on the severity of COVID-19 infection in multiple sclerosis patients" on your journal. This article is protected by copyright. All rights reserved.